Table 4.
Type of rheumatic diseases flare among vaccinated patients.
| Flare | Disease flare after vaccination | Days after vaccination disease flare had occurred | Frequency of Flare types | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes No. (%) | No No. (%) | Types | Frequency | ||||||
| Pfizer Median (range) | 49(9.9) | 444(90.1) | 5(1–30) | Arthritis | 27(5.5) | ||||
| Arthralgia | 23(4.7) | ||||||||
| Fatigue | 13(2.6) | ||||||||
| Cutaneous flare | 6(1.2) | ||||||||
| Neuro-psychiatric | 1(0.2) | ||||||||
| Mouth ulcer | 2(0.4) | ||||||||
| LN enlargements | 1(0.2) | ||||||||
| Fever | 2(0.4) | ||||||||
| Renal | 1(0.2) | ||||||||
| Backache | 2(0.4) | ||||||||
| Arthralgia | 7(6.5) | ||||||||
| Sinopharm Median (range) | 11(10.3) | 96(89.7) | 4(1–20) | Arthritis | 3(2.8) | ||||
| Cutaneous flare | 2(1.9) | ||||||||
| Fatigue | 2(1.9) | ||||||||
| Arthralgia | 4(6.6) | ||||||||
| Fatigue | 2(3.3) | ||||||||
| AstraZeneca Median (range) | 6(8.2) | 55(91.8) | 7.5(2–30) | Arthritis | 1(1.6) | ||||
| Muscle weakness | 1(1.6) | ||||||||
| Neuro-psychiatric | 1(1.6) | ||||||||
LN: lymph node.